High Point Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20.4K Buy
+715
New +$19K 0.02% 200
2026
Q2
– Sell
-100
Closed -$2.81K – 257
2026
Q1
$2.81K Buy
+100
New +$2.66K ﹤0.01% 240

Other funds holding PFE

High Point Wealth Management's PFE Position: Q3 2026 in Review

High Point Wealth Management opened a new position in Pfizer (PFE) in Q3 2026: 715 shares worth $20.4K. The stake represents 0.02% of the portfolio and ranks #200 among its holdings. This is a return to the name: High Point Wealth Management previously reported a position in PFE as recently as Q1 2026.

High Point Wealth Management first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • High Point Wealth Management held 715 shares of Pfizer worth $20.4K as of Q3 2026.
  • Pfizer was a new High Point Wealth Management position in Q3 2026.
  • Pfizer made up 0.02% of High Point Wealth Management's portfolio in Q3 2026, its #200 holding.
  • High Point Wealth Management first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
  • 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on High Point Wealth Management's 13F filing for Q3 2026, filed 5 Nov 2026.